XML 194 R107.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Equity Method and Other Investments - Term Loan Receivable, Convertible Debt, and Warrant (Details) - USD ($)
$ in Millions
12 Months Ended
Nov. 28, 2016
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2016
Sep. 30, 2015
BioCision, LLC          
Schedule of Equity Method Investments [Line Items]          
Loan receivable       $ 1.5  
Annual interest rate (percent)       10.00%  
Loan receivable, carrying value $ 1.6        
Convertible debt securities and warrant, purchase price         $ 5.0
Loan receivable, fair value 1.6        
Convertible Debt Securities          
Schedule of Equity Method Investments [Line Items]          
Loss on settlement of financial instruments 0.2        
Loss on settlement of financial instruments, consolidated statements of operations   us-gaap:OtherNonoperatingIncomeExpense us-gaap:OtherNonoperatingIncomeExpense    
Convertible Debt Securities | BioCision, LLC          
Schedule of Equity Method Investments [Line Items]          
Investment maturity period       5 years  
Annual interest rate (percent)       9.00%  
Convertible debt securities, carrying value 5.8        
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Convertible Debt Securities | BioCision, LLC          
Schedule of Equity Method Investments [Line Items]          
Convertible debt securities, fair value 5.6        
Fair Value, Measurements, Recurring | Warrants | Significant Unobservable Inputs (Level 3) | BioCision, LLC | Maximum          
Schedule of Equity Method Investments [Line Items]          
Stock warrant $ 0.1